These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2547138)

  • 21. The effect in post-menopausal women of natural human and artificial oestrogens on the concentration in serum of prolactin.
    Andersen JR; Schroeder E; Lebech PE
    Acta Endocrinol (Copenh); 1980 Dec; 95(4):433-7. PubMed ID: 6779473
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of various replacement oestrogens on hepatic transcortin synthesis in climacteric women.
    Schwartz U; Volger H; Schneller E; Moltz L; Hammerstein J
    Acta Endocrinol (Copenh); 1983 Jan; 102(1):103-6. PubMed ID: 6297207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oestrogens, gonadotrophins and SHBG during oral and cutaneous administration of oestradiol-17 beta to menopausal women.
    Fåhraeus L; Larsson-Cohn U
    Acta Endocrinol (Copenh); 1982 Dec; 101(4):592-6. PubMed ID: 6818806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Relation between plasma hormone profiles, symptoms, and response to oestrogen treatment in women approaching the menopause.
    Chakravarti S; Collins WP; Thom MH; Studd JW
    Br Med J; 1979 Apr; 1(6169):983-5. PubMed ID: 219937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of long-term therapy with estrogen and progesterone on the endometrium of post-menopausal women.
    Varma TR
    Acta Obstet Gynecol Scand; 1985; 64(1):41-6. PubMed ID: 2983513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of low dose oestrogen on circulating prolactin. LH and FSH levels in post-menopausal women.
    Robyn C; Vekemans M
    Acta Endocrinol (Copenh); 1976 Sep; 83(1):9-14. PubMed ID: 989226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of pharmacodynamic properties of various estrogen formulations.
    Mashchak CA; Lobo RA; Dozono-Takano R; Eggena P; Nakamura RM; Brenner PF; Mishell DR
    Am J Obstet Gynecol; 1982 Nov; 144(5):511-8. PubMed ID: 6291391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of serum oestrogen concentrations in post-menopausal women taking oestrone sulphate and oestradiol.
    Anderson AB; Sklovsky E; Sayers L; Steele PA; Turnbull AC
    Br Med J; 1978 Jan; 1(6106):140-2. PubMed ID: 620226
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of conjugated oestrogens on circulating oestradiol, oestrone, LH, FSH and prolactin levels in postmenopausal women.
    Luisi M; Franchi F; Argenio GF; Barletta D; Romano MR; Bernini GP; Gasperi M; Sgrilli R
    Int J Tissue React; 1981 Jun; 3(2):77-81. PubMed ID: 6799393
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K; Lunell NO; Zador G
    Gynecol Obstet Invest; 1978; 9(6):304-11. PubMed ID: 754992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative pharmacokinetics of oestradiol, oestrone, oestrone sulfate and "conjugated oestrogens" after oral administration.
    Schindler AE; Bolt HM; Zwirner M; Hochlehnert G; Göser R
    Arzneimittelforschung; 1982; 32(7):787-91. PubMed ID: 6289846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of low-dose piperazine oestrone sulphate and low-dose levonorgestrel on blood lipid levels in post-menopausal women.
    Wren B; Garrett D
    Maturitas; 1985 Jul; 7(2):141-6. PubMed ID: 3929024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma hormone levels in women receiving new oral contraceptives containing ethinyl estradiol plus levonorgestrel or desogestrel.
    Gaspard UJ; Romus MA; Gillain D; Duvivier J; Demey-Ponsart E; Franchimont P
    Contraception; 1983 Jun; 27(6):577-90. PubMed ID: 6225622
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pulsatile luteinizing hormone patterns in long term oral contraceptive users.
    Hemrika DJ; Slaats EH; Kennedy JC; de Vries Robles-Korsen TJ; Schoemaker J
    J Clin Endocrinol Metab; 1993 Aug; 77(2):420-6. PubMed ID: 8345046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How do androgens affect episodic gonadotrophin secretion in postmenopausal women?
    Rossmanith WG; Beuter M; Benz R; Lauritzen C
    Maturitas; 1991 Oct; 13(4):325-35. PubMed ID: 1775085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of oral estrogen therapy on serum FSH and LH levels in young women with hyper-gonadotrophic ovarian failure.
    Leis D; Braun S
    Arch Gynecol; 1981; 230(3):225-30. PubMed ID: 6264865
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine studies in postmenopausal women during oral replacement therapy with unconjugated oestrogens.
    Vasquez JM; Samaras CA; Nezhat C
    Reproduccion; 1982; 6(2):49-59. PubMed ID: 6216132
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovarian function during oestrogen-progestin replacement treatment in pre-menopausal women.
    Ylöstalo P; Vartiainen E; Stenman UH; Widholm O
    Maturitas; 1986 Mar; 8(1):19-27. PubMed ID: 3010055
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen therapy.
    Larsson-Cohn U; Johansson ED; Kågedal B; Wallentin L
    Br J Obstet Gynaecol; 1978 May; 85(5):367-72. PubMed ID: 646971
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restoration of the gonadotrophin response to LH-RH and oestrogen administration in patients after molar abortion.
    Miyake A; Aono T; Tanizawa O; Kurachi H; Kurachi K
    Acta Endocrinol (Copenh); 1979 May; 91(1):30-5. PubMed ID: 222100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.